Summary
Pfizer Inc. filed an 8-K report on October 24, 2001, primarily to incorporate by reference a press release issued on October 17, 2001. This press release contained Pfizer's financial results for the third quarter and the first nine months of 2001. Investors should refer to the referenced press release for the detailed financial performance and operational highlights during this period. The report itself is brief, serving as a notification mechanism to the SEC about the public disclosure of these important financial figures. The key takeaway for investors is to access the October 17th press release for comprehensive insights into Pfizer's performance, including revenue, earnings, and any segment-specific information or forward-looking statements that were made at that time.
Key Highlights
- 1Pfizer Inc. filed an 8-K report on October 24, 2001.
- 2The 8-K incorporates by reference a press release dated October 17, 2001.
- 3The press release announces Pfizer's financial results for the third quarter of 2001.
- 4The press release also covers financial results for the first nine months of 2001.
- 5This filing serves as official notification of the public release of these financial results.
- 6Investors are directed to the October 17, 2001 press release for detailed financial information.